Large scale analyses of genotype-phenotype relationships of glycine decarboxylase mutations and neurological disease severity.

Abstract

Monogenetic diseases provide unique opportunity for studying complex, clinical states that underlie neurological severity. Loss of glycine decarboxylase (GLDC) can severely impact neurological development as seen in non-ketotic hyperglycinemia (NKH). NKH is a neuro-metabolic disorder lacking quantitative predictors of disease states. It is characterized by elevation of glycine, seizures and failure to thrive, but glycine reduction often fails to confer neurological benefit, suggesting need for alternate tools to distinguish severe from attenuated disease. A major challenge has been that there are 255 unique disease-causing missense mutations in GLDC, of which 206 remain entirely uncharacterized. Here we report a Multiparametric Mutation Score (MMS) developed by combining in silico predictions of stability, evolutionary conservation and protein interaction models and suitable to assess 251 of 255 mutations. In addition, we created a quantitative scale of clinical disease severity comprising of four major disease domains (seizure, cognitive failure, muscular and motor control and brain-malformation) to comprehensively score patient symptoms identified in 131 clinical reports published over the last 15 years. The resulting patient Clinical Outcomes Scores (COS) were used to optimize the MMS for biological and clinical relevance and yield a patient Weighted Multiparametric Mutation Score (WMMS) that separates severe from attenuated neurological disease (p = 1.2 e-5). Our study provides understanding for developing quantitative tools to predict clinical severity of neurological disease and a clinical scale that advances monitoring disease progression needed to evaluate new treatments for NKH.

• Authors: Joseph Farris, Barbara Calhoun, Md Suhail Alam, Shaun Lee, Kasturi Haldar
• Journal: PLoS computational biology (PLoS Comput Biol) Vol. 16 Issue 5 Pg. e1007871 (05 2020) ISSN: 1553-7358 [Electronic] United States
• PMID: 32421718 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Glycine Dehydrogenase (Decarboxylating)

Topics

• Gene Expression Regulation, Enzymologic
• Genotype
• Glycine Dehydrogenase (Decarboxylating) (genetics)
• Humans
• Hyperglycinemia, Nonketotic (diagnosis, genetics, pathology)
• Mutation, Missense
• Phenotype
• Severity of Illness Index